Loading...
•
Sep 30, 2022
Vericel Q3 2022 Earnings Report
Vericel reported third quarter financial results with total net product revenue of $38.6 million.
Key Takeaways
Vericel Corporation reported a strong third quarter with a 12% increase in total net revenue to $38.6 million. MACI net revenue increased by 30% to $31.0 million. The company reported a net loss of $6.6 million, or $0.14 per share, and a non-GAAP adjusted EBITDA of $3.3 million.
Total net revenue reached $38.6 million.
MACI net revenue increased 30% to $31.0 million.
Gross margin was 65%.
The company had approximately $133 million in cash and investments with no debt as of September 30, 2022.
Revenue by Segment
Forward Guidance
Vericel expects total net revenue to be in the range of $164 to $166 million, MACI revenue to be approximately $130 to $132 million, total burn care revenue to be approximately $34 million, gross margin to be in the mid-60% range, and adjusted EBITDA margin in the mid-teens % range.
Positive Outlook
- Total net revenue expected to be in the range of $164 to $166 million
- MACI revenue expected to be approximately $130 to $132 million
- Total burn care revenue, including Epicel and NexoBrid, expected to be approximately $34 million
- Gross margin expected to be in the mid-60% range
- Adjusted EBITDA margin in the mid-teens % range
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...